Ciptapangan
Ciptapangan
SIGN IN ACCOUNT
Email / NIK:
Password:
 Remember my login ID
Forgot Your Password?


Job Application Form
Job Application Form
CURRENCY
Currency Buy Rate Sell Rate
USD 14,296.00 14,296.000
AUD 11,047.08 11,047.080
HKD 1,842.47 1,842.470
MYR 3,464.94 3,464.940
NZD 10,328.60 10,328.600
NOK 1,717.09 1,717.090
GBP 20,240.93 20,240.930
SGD 10,798.97 10,798.970
CHF 15,894.21 15,894.210
JPY 13,032.88 13,032.880
MMK 9.02 9.020
INR 196.08 196.080
KWD 47,438.87 47,438.870
PKR 92.37 92.370
PHP 299.26 299.260
LKR 72.23 72.230
THB 458.68 458.680
BND 10,781.15 10,781.150
EUR 17,424.48 17,424.480
CNY 2,238.48 2,238.480
KRW 12.85 12.850
Last update: 09/06/21 13:59:44
1 troy oz

=

  31.10 gram
1 US bushel (bu)

=

  35.24 liter
1 barrel (bbl)

=

158.97 liter

Ciptapangan Visitor
Scientists seek new ways to speed up bird-flu vaccine
posted by admin on 08/05/06

"If the pandemic happens tomorrow or next year, we're in trouble”

CLEVELAND - Health scientists and engineers are racing to find new ways to produce a vaccine that will protect people from the threat of a worldwide bird-flu pandemic. 

They are working with plants, insects and bacteria that they hope can churn out huge quantities of vaccine more efficiently than the present, agonizingly slow system of using millions of chicken eggs. 

An adequate supply of vaccine for the lethal H5N1 flu virus will not be available for years, experts from seven countries, 44 universities and 60 biotechnology companies agreed at a recent conference sponsored by the National Academy of Sciences at Case Western Reserve University. 

"We're not ready," said Bruce Gellin, the director of the National Vaccine Program Office at the Department of Health and Human Services. "If it happens tomorrow or next year, we're in trouble. It's a sobering picture." 

Klaus Stohr, the head of the World Health Organization Influenza Team, said that one dose of a safe, effective vaccine for H5N1 was "going to be much more valuable than diamonds." 

In the past three years, bird flu -- also known as avian flu -- has killed millions of birds, a small number of mammals and 109 humans in Asia, Europe and Africa. So far, it is overwhelmingly a bird disease, but it is mutating rapidly and might change into a form that could pass among humans. 

The 2006 spring bird-migration season is just beginning, raising fears the virus could reach the Western Hemisphere this year. 

Ducks and other wild birds can carry a virus along an established "flyway" through Alaska to Washington state, Oregon, California, Arizona and Mexico. A sick or dead duck could be a warning signal. 

About 30 potential vaccines are being tested for safety and effectiveness in the United States and Europe, but the results have been disappointing, Stohr said. 

The tests show that high doses of vaccine -- and at least two shots -- are needed to prevent infection, which means much greater quantities will be necessary, far more than can be produced by current technology. 

There will be no breakthrough this year, Stohr said. "It will take six years to have enough vaccine for 20 percent of the world's population. It may take eight to 10 years to solve the problem." 

Furthermore, the virus keeps changing, so a vaccine developed for one type of flu may not work against another variant. The H5N1 type that began in Asia already has split into two main branches. 

"They are different enough that we may need two stockpiles of vaccine," said James Matthews, the senior science-policy director at Sanofi Pasteur, a vaccine manufacturer in Swiftwater, Pa. 

To meet the challenge, scientists are trying to grow vaccines in various kinds of cells, which they multiply in giant vats, instead of in eggs. 

Yeast, tobacco leaf, soybeans and duckweed cell cultures avoid many of the problems encountered with eggs, but that still does not speed up the process much. 

"You can't make cells divide any faster," said Dr. Patrick Scannon, the chief scientist at Xoma Ltd., a biotechnology firm in Berkeley. 

Researchers also are seeking novel methods to deliver vaccine to patients without the necessity of refrigeration and sterile needles, which can pose serious obstacles in many parts of the world. 

"Theoretically, you could have a vaccine in a tomato," said Alan Shaw, the president of VacInnate, a biotechnology company in New Haven, Conn. 

Eating the tomato would provide additional protection after the first inoculation, similar to a booster shot, he said.

Previous News     |      Next News

Current Rating: 0.000 (0 users)

Rate this news:



Online Pooling